Accordingly, Zhu et al. showed that GA (20–60 mg/kg, intragastric injection) improved the histological alteration in TNSB-induced colitis, by anti-inflammatory mechanisms which include the NF-κB impairment. Here, NFKB1 is linked to colitis.